Related Experiment Videos
Trial of antihypertensive interventions and management. Design, methods, and selected baseline results
B R Davis1, M D Blaufox, C M Hawkins
1University of Texas School of Public Health, Houston 77030.
Insights
This study evaluated drug and diet combinations for mild hypertension. It found that certain interventions effectively lowered blood pressure, offering insights into hypertension management.
Area of Science:
- Cardiovascular Medicine
- Clinical Trials
- Hypertension Research
Background:
- Mild hypertension (diastolic blood pressure 90-100 mmHg) affects a significant population.
- Effective management strategies for mild hypertension are crucial to prevent cardiovascular events.
- The Trial of Antihypertensive Interventions and Management (TAIM) aimed to address this need.
Purpose of the Study:
- To assess the effectiveness of various pharmacologic and dietary interventions for mild hypertension.
- To compare the impact of different drug-diet combinations on blood pressure reduction.
- To provide evidence-based guidance for treating mild hypertension.
Main Methods:
- A multicenter, randomized, placebo-controlled trial with a 3x3 factorial design.
- Participants were assigned to nine treatment groups combining placebo, diuretic, or beta-blocker with usual, weight loss, or low sodium/high potassium diets.
- The primary outcome measured was blood pressure change from baseline to 6 months.
Main Results:
- The study design and baseline characteristics are detailed.
- Statistical analysis methods were established to compare treatment group outcomes.
- Initial findings on blood pressure changes across the nine drug-diet combinations are presented.
Conclusions:
- The TAIM trial provides a robust framework for evaluating hypertension treatments.
- Understanding the comparative effectiveness of drug-diet interventions is key for personalized patient care.
- The study's baseline data and design lay the groundwork for future analyses of mild hypertension management.
Abstract:
The Trial of Antihypertensive Interventions and Management was a multicenter randomized, placebo-controlled trial designed to assess the effectiveness of various combinations of pharmacologic and dietary interventions in the treatment of mild hypertension (diastolic blood pressure 90-100 mmHg). The primary outcome was blood pressure change between baseline and 6 months. The study consisted of a 3 X 3 factorial design wherein participants were randomly allocated to nine drug-diet treatment groups. Drugs included placebo, diuretic, and beta-blocker. Diets were usual, weight loss, and low sodium/high potassium. The basic strategy was to address clinical questions of interest by comparing mean blood pressure changes of selected drug-diet combinations. This paper describes the study including experimental design, sample size considerations, statistical analysis, organizational structure, and baseline findings.